- Release Date: 07/06/21 09:07
- Summary: Media release - First stroke patient with afamelanotide
- Price Sensitive: No
- Download Document 173.47KB
- Forums
- ASX - By Stock
- CUV
- Ann: Media release - First stroke patient with afamelanotide
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.10%
!
$10.34

Ann: Media release - First stroke patient with afamelanotide
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.34 |
Change
-0.010(0.10%) |
Mkt cap ! $517.7M |
Open | High | Low | Value | Volume |
$10.35 | $10.44 | $10.18 | $221.2K | 21.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 229 | $10.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.34 | 28 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 10.320 |
1 | 50 | 10.310 |
1 | 52 | 10.300 |
1 | 53 | 10.290 |
2 | 200 | 10.280 |
Price($) | Vol. | No. |
---|---|---|
10.340 | 9 | 1 |
10.350 | 80 | 2 |
10.360 | 50 | 1 |
10.370 | 106 | 3 |
10.380 | 82 | 2 |
Last trade - 11.39am 04/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online